69 FR 74 pgs. 20631-20632 - Agency Information Collection Activities; Announcement of OMBApproval; Postmarketing Studies for Human Drugs and Licensed BiologicalProducts; Status Report
Type: NOTICEVolume: 69Number: 74Pages: 20631 - 20632
Docket number: [Docket No. 2003N-0267]
FR document: [FR Doc. 04-8612 Filed 4-15-04; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2003N-0267]
Agency Information Collection Activities; Announcement of OMBApproval; Postmarketing Studies for Human Drugs and Licensed BiologicalProducts; Status Report
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) isannouncing that a collection of information entitled "PostmarketingStudies for Human Drugs and Licensed Biological Products; StatusReport" has been approved by the Office of Management and Budget(OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
JonnaLynn P.Capezzuto, Office of Information Resources Management (HFA-250), Foodand Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,301-827-4659.
SUPPLEMENTARY INFORMATION:
In the FederalRegister of January 16, 2004 (69 FR 2601), the agency announced thatthe proposed information collection had been submitted to OMB for reviewand clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor,and a person is not required to respond to, a collection of informationunless it displays a currently valid OMB control number. OMB has nowapproved the information collection and has assigned OMB control number0910-0433. The approval expires on March 31, 2007. A copy of thesupporting statement for this information collection is available on theInternet at http://www.fda.gov/ohrms/dockets .
Dated: April 9, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-8612 Filed 4-15-04; 8:45 am]
BILLING CODE 4160-01-S